Lee et al. found that downregulated ADAMTS1 incorporating A2M could contribute to the lung adenocarcinoma progression and change TME, and was also associated with the prognosis of lung adenocarcinoma patients [18]. This evidence concerns the gene ADAMTS1 and lung adenocarcinoma.